Postsynaptic NO/cGMP increases NMDA receptor currents via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus

Cereb Cortex. 2014 Jul;24(7):1923-36. doi: 10.1093/cercor/bht048. Epub 2013 Feb 28.

Abstract

The nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) signaling cascade participates in the modulation of synaptic transmission. The effects of NO are mediated by the NO-sensitive cGMP-forming guanylyl cyclases (NO-GCs), which exist in 2 isoforms with indistinguishable regulatory properties. The lack of long-term potentiation (LTP) in knock-out (KO) mice deficient in either one of the NO-GC isoforms indicates the contribution of both NO-GCs to LTP. Recently, we showed that the NO-GC1 isoform is located presynaptically in glutamatergic neurons and increases the glutamate release via hyperpolarization-activated cyclic nucleotide (HCN)-gated channels in the hippocampus. Electrophysiological analysis of hippocampal CA1 neurons in whole-cell recordings revealed a reduction of HCN currents and a hyperpolarizing shift of the activation curve in the NO-GC2 KOs associated with reduced resting membrane potentials. These features were mimicked in wild-type (WT) neurons with an NO-GC inhibitor. Analysis of glutamate receptors revealed a cGMP-dependent reduction of NMDA receptor currents in the NO-GC2 KO mice, which was mimicked in WT by HCN channel inhibition. Lowering extracellular Mg(2+) increased NMDA receptor currents in the NO-GC2 KO and allowed the induction of LTP that was absent at physiological Mg(2+). In sum, our data indicate that postsynaptic cGMP increases the N-methyl-D-aspartate (NMDA) receptor current by gating HCN channels and thereby is required for LTP.

Keywords: HCN channels; KO; NMDA receptor; NO; cGMP; guanylyl cyclase; hippocampus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Local / pharmacology
  • Animals
  • Animals, Newborn
  • CA1 Region, Hippocampal / cytology*
  • Cyclic GMP / metabolism*
  • Cyclic GMP / pharmacology
  • Electric Stimulation
  • Excitatory Amino Acid Antagonists / pharmacology
  • Guanylate Cyclase / genetics
  • Guanylate Cyclase / metabolism
  • Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels / metabolism
  • In Vitro Techniques
  • Lidocaine / analogs & derivatives
  • Lidocaine / pharmacology
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / physiology*
  • Mice
  • Mice, Knockout
  • Neurons / drug effects
  • Neurons / physiology*
  • Nitric Oxide / deficiency*
  • Nitric Oxide / genetics
  • Patch-Clamp Techniques
  • Pyrimidines / pharmacology
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Tetraethylammonium / pharmacology

Substances

  • Anesthetics, Local
  • Excitatory Amino Acid Antagonists
  • Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
  • Pyrimidines
  • Receptors, N-Methyl-D-Aspartate
  • ICI D2788
  • QX-314
  • Nitric Oxide
  • Tetraethylammonium
  • Lidocaine
  • Guanylate Cyclase
  • Cyclic GMP